Skip to main content
. 2021 Dec 12;28(6):5304–5317. doi: 10.3390/curroncol28060443

Figure 4.

Figure 4

MAP vs. AP in adult patients with osteosarcoma. (a) Progression-free survival in the adult cohort for patients treated with MAP (blue curve) versus patients treated with AP (orange curve). (b) Overall survival for patients treated with MAP (blue curve) and patients treated with AP (orange curve) in the adult cohort.